Lilly stock droops after rival claims faster-acting impotence pill
California-based Vivus claims its drug acts in 30 minutes, compared with about 2 hours for Lilly’s Cialis.
Health Care Businesses
Articles
Arcadia sees bigger quarterly loss on lower revenue
Health care company Arcadia Resources Inc. saw growth in pharmacy business, offset by slower medical staffing sales.
Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
Thanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
Hill-Rom’s fourth quarter profit exceeds expectations
The Batesville-based maker of hospital equipment reported profit of $26.4 million, or 42 cents per share, in the period ended
Sept. 30.
Lilly to pay Utah $24 million to settle Zyprexa suit
Eli Lilly and Co. has agreed to pay Utah $24 million to settle a lawsuit claiming the company improperly marketed the antipsychotic
drug Zyprexa.
Arcadia adds Goldsmith to board, seeks $11M in offering
Indianapolis-based Arcadia Resources Inc. has added former Indianapolis Mayor Steve Goldsmith to its board and plans to raise
$11.1 million in a registered direct stock offering.
UPDATE: Life science firm to add 100 jobs at Park 100
California-based life science firm Beckman Coulter Inc. is moving its precision plastics injection molding operation
to the Park 100 business park on Indianapolis’ northwest side, making what it calls a multimillion-dollar investment in the
operation.
Struggling Bioanalytical Systems adds outsider to board
Shareholders are starting to make inroads in their effort to turn struggling West Lafayette-based Bioanalytical Systems Inc. in a new direction.
Health care businesses at risk in House proposal
The health care overhaul bill produced by House Democrats would impose an array of new taxes, fees and government mandates
on major players in the health industry, including drug companies and big medical-device makers headquartered in Indiana.
Lilly opens new biotech center in San Diego
Lilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
Doctors balk at Senate attempt to cut out wasteful health care spending
The big goal of health care reform is to cut wasteful spending to pay for expanded health insurance coverage. But the way
the Senate Finance Committee bill tries to do that would be, according to some doctors, “disastrous.”
TechPoint to focus on IT firms specializing in medical, life sciences sectors
Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
Lilly to move 1,000 from Faris campus
As it shrinks its work force, Indianapolis-based pharmaceutical firm Eli Lilly and Co. will move more than 1,000 employees to its corporate
center
by mid-2010.
Lilly settles Zyprexa case with S. Carolina for $45M
South Carolina Attorney General Henry McMaster said Friday that the state has reached a $45 million settlement with drug maker
Eli Lilly and Co. over the company’s marketing of an anti-psychotic drug.
Cook Group Inc. owner says health reform’s tax on medical devices could kill jobs
Bloomington-based Cook Group Inc. might have to cut as many as 1,000 local jobs if Congress enacts a tax on medical devices
to pay for health care reform, company founder Bill Cook said in an interview.
Eli Lilly CEO banking on new drug pipeline
CEO John Lechleiter says Lilly’s pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He’s betting there will be a fourth.
Zimmer profits fall, but beat expectations
The Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.
Lilly, GE announce cancer diagnostic breakthrough
Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
Bristol-Myers Squibb plans 113 job cuts in southern Indiana
Drugmaker Bristol-Myers Squibb Co. plans to close one of its southern Indiana facilities and cut jobs at another.
Lilly reports $942 million profit in third quarter
Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.